1,0
3 giu 2026
Ex dipendente, più di 3 anni
New Haven, CT
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
•it pays, but not a serious company. •no new data in 5-10 years, Viatris is a Pfizer pet project went wrong.
Svantaggi
•New England respiratory was an unmitigated disaster. •Very little competent management , the company doesn’t seem interested in succeeding.